[
  {
    "ts": null,
    "headline": "Biogen Inc. (BIIB) Stifel 2025 Virtual CNS Forum Conference (Transcript)",
    "summary": "Biogen Inc. (NASDAQ:BIIB) Stifel 2025 Virtual CNS Forum Conference March 18, 2025 10:15 AM ETCompany ParticipantsPriya Singhal - Head of...",
    "url": "https://finnhub.io/api/news?id=370855ca130143ac73cb2156615c7ece21d4cd6f212c64a49957eb6fdfbb65e5",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742308764,
      "headline": "Biogen Inc. (BIIB) Stifel 2025 Virtual CNS Forum Conference (Transcript)",
      "id": 133234616,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "BIIB",
      "source": "SeekingAlpha",
      "summary": "Biogen Inc. (NASDAQ:BIIB) Stifel 2025 Virtual CNS Forum Conference March 18, 2025 10:15 AM ETCompany ParticipantsPriya Singhal - Head of...",
      "url": "https://finnhub.io/api/news?id=370855ca130143ac73cb2156615c7ece21d4cd6f212c64a49957eb6fdfbb65e5"
    }
  },
  {
    "ts": null,
    "headline": "Health Canada approves Biogen’s Skyclarys for Friedreich’s ataxia",
    "summary": "The approval of the therapy is supported by the pivotal, placebo-controlled MOXIe Part 2 trial.",
    "url": "https://finnhub.io/api/news?id=51bcd5f3a264dc154bc3dc376745cdddc39a0c691b523fbf2ec5daa5818ee214",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742297727,
      "headline": "Health Canada approves Biogen’s Skyclarys for Friedreich’s ataxia",
      "id": 133327026,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BIIB",
      "source": "Yahoo",
      "summary": "The approval of the therapy is supported by the pivotal, placebo-controlled MOXIe Part 2 trial.",
      "url": "https://finnhub.io/api/news?id=51bcd5f3a264dc154bc3dc376745cdddc39a0c691b523fbf2ec5daa5818ee214"
    }
  }
]